Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
2.88
-0.05 (-1.71%)
At close: Jun 16, 2025, 3:59 PM
2.88
0.17%
Pre-market: Jun 17, 2025, 05:34 AM EDT
-1.71% (1D)
| Bid | 2.8 |
| Market Cap | 309.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -258.03M |
| EPS (ttm) | -2.63 |
| PE Ratio (ttm) | -1.09 |
| Forward PE | -1.75 |
| Analyst | Buy |
| Ask | 2.96 |
| Volume | 3,463,548 |
| Avg. Volume (20D) | 4,807,623 |
| Open | 2.97 |
| Previous Close | 2.93 |
| Day's Range | 2.81 - 3.06 |
| 52-Week Range | 2.19 - 26.98 |
| Beta | 0.68 |
About RCKT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCKT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RCKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-62.84%
Rocket Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago
+11.06%
Rocket Pharmaceuticals shares are trading higher after the company presented preliminary data from its Phase 1 trial of RP-A601.
